B Cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kB regulated c-myc transcription

Molecular Cell

Volumn 10, Issue 6, 2002, Pages 1283-1294

  Grumont, Raelene J ^a   Strasser, Andreas ^a   Gerondakis, Steve ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; DIMER; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LY 29002; MITOGENIC AGENT; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0036928333     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00779-7     Document Type: Article

References (34)

1. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 318:1985;533-538.
2. Alexander W.S., Schrader J.W., Adams J.M. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice. Mol. Cell. Biol. 7:1987;1436-1444.
3. Baldwin A.S. Jr. The NF-κB and IκB proteins. new discoveries and insights Annu. Rev. Immunol. 14:1996;649-683.
4. Barboric M., Nissen R.M., Kanazawa S., Jabrane-Ferrat N., Peterlin B.M. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell. 8:2001;327-337.
5. Conlon I., Raff M. Size control in animal development. Cell. 96:1999;235-244.
6. Eisenman R.N. Deconstructing myc. Genes Dev. 15:2001;2023-2030.
7. Epinat J.-C., Gilmore T.D. Diverse agents act at multiple levels to inhibit the Rel/NF-kB signal transduction pathway. Oncogene. 18:1999;6896-6909.
8. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:2002;1472-1487.
9. Gerondakis S., Grossmann M., Nakamura Y., Pohl T., Grumont R. Genetic approaches in mice to understand Rel/NF-κB and IκB function. transgenics and knockouts Oncogene. 18:1999;6888-6895.
10. Grumont R.J., Gerondakis S. The subunit composition of NF-κB complexes change during B cell development. Cell Growth Diff. 5:1994;1321-1331.
11. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W.C., Gerondakis S. B lymphocytes differentially use the Rel and Nuclear Factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
12. Grumont R.J., Rourke I.J., Gerondakis S. Rel-dependent induction of A1 transcription is required to protect cells from antigen receptor ligation induced apoptosis. Genes Dev. 13:1999;400-411.
13. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
14. Iritani B.M., Eisenman R.N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA. 96:1999;13180-13185.
15. Johnston L.A., Prober D.A., Edgar B.A., Eisenman R.N., Gallant P. Drosophila myc regulates cellular growth during development. Cell. 98:1999;779-790.
16. Karin M. How NF-κB is activated. the role of the IκB kinase (IKK) complex Oncogene. 18:1999;6867-6874.
17. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1995;1965-1977.
18. Langdon W.Y., Harris A.W., Cory S., Adams J.M. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell. 47:1986;11-18.
19. Lee H., Arsura M., Wu M., Duyao M., Buckler A.J., Sonenshein G.E. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1995;1169-1177.
20. Levens D. Disentangling the MYC web. Proc. Natl. Acad. Sci. USA. 99:2002;5757-5759.
21. Nakamura Y., Grumont R.J., Gerondakis S. NF-kB1 can inhibit v-abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression. Mol. Cell. Biol. 22:2002;5563-5574.
22. Pohl T., Gugasyan R., Grumont R.J., Strasser A., Metcalf D., Tarlinton D., Sha W.C., Baltimore D., Gerondakis S. The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc. Natl. Acad. Sci. USA. 99:2002;4514-4519.
23. Rayet B., Gelinas C. Abberant rel/nfkb genes and activity in human cancer. Oncogene. 18:1999;6938-6947.
24. Richards J.D., Dave S.H., Chou C.H., Mamchak A.A., DeFranco A.L. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166:2001;3855-3864.
25. Schmidt E.V. The role of c-myc in cellular growth control. Oncogene. 18:1999;2988-2996.
26. Schuhmacher M., Staege M.S., Pajic A., Polack A., Weidle U.H., Bornkamm G.W., Eick D., Kohlhuber F. Control of cell growth by c-myc in the absence of division. Curr. Biol. 9:1999;1255-1258.
27. Sears R., Nuckolls F., Haura E., Taya Y., Tamai K., Nevins J.R. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2000;2501-2514.
28. Sha W.C., Liou H.-C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
29. Sizemore N., Lerner N., Dombrowski N., Sakarai H., Stark G.R. Distinct roles of the Ikappa B kinase alpha and beta subunits liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J. Biol. Chem. 277:2002;3863-3869.
30. Stocker H., Hafen E. Genetic control of cell size. Curr. Opin. Genet. Dev. 10:2000;529-535.
31. Trumpp A., Refaeli Y., Oskarsson T., Gasser S., Murphy M., Martin G.R., Bishop J.M. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature. 414:2001;768-773.
32. Whiteside S.T., Israel A. IκB proteins. structure, function and regulation Semin. Cancer Biol. 8:1997;75-82.
33. Wicker L.S., Boltz R.C., Matt V., Nicols E.A., Peterson L.B., Sigal N.H. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur. J. Immunol. 20:1990;2277-2283.
34. Wright S., Bishop J.M. DNA sequences that mediate attenuation of transcription from mouse protooncogene myc. Proc. Natl. Acad. Sci. USA. 86:1989;505-509.